KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Invested Capital (2017 - 2025)

Historic Invested Capital for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to $53.5 million.

  • Bionano Genomics' Invested Capital rose 164.58% to $53.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.5 million, marking a year-over-year increase of 164.58%. This contributed to the annual value of $39.2 million for FY2024, which is 6083.15% down from last year.
  • Per Bionano Genomics' latest filing, its Invested Capital stood at $53.5 million for Q3 2025, which was up 164.58% from $49.1 million recorded in Q2 2025.
  • Bionano Genomics' 5-year Invested Capital high stood at $377.6 million for Q1 2021, and its period low was $39.2 million during Q4 2024.
  • Its 5-year average for Invested Capital is $191.7 million, with a median of $218.6 million in 2023.
  • As far as peak fluctuations go, Bionano Genomics' Invested Capital surged by 286005.02% in 2021, and later plummeted by 6320.25% in 2024.
  • Quarter analysis of 5 years shows Bionano Genomics' Invested Capital stood at $341.1 million in 2021, then decreased by 25.73% to $253.3 million in 2022, then plummeted by 60.52% to $100.0 million in 2023, then plummeted by 60.83% to $39.2 million in 2024, then surged by 36.69% to $53.5 million in 2025.
  • Its last three reported values are $53.5 million in Q3 2025, $49.1 million for Q2 2025, and $52.0 million during Q1 2025.